The Impact of the COVID-19 “Infodemic” on Drug-Utilization Behaviors: Implications for Pharmacovigilance
出版年份 2020 全文链接
标题
The Impact of the COVID-19 “Infodemic” on Drug-Utilization Behaviors: Implications for Pharmacovigilance
作者
关键词
-
出版物
DRUG SAFETY
Volume 43, Issue 8, Pages 699-709
出版商
Springer Science and Business Media LLC
发表日期
2020-06-23
DOI
10.1007/s40264-020-00965-w
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Structure analysis of the receptor binding of 2019-nCoV
- (2020) Yun Chen et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Topology comparison of Twitter diffusion networks effectively reveals misleading information
- (2020) Francesco Pierri et al. Scientific Reports
- Identification of Falsified Chloroquine Tablets in Africa at the Time of the COVID-19 Pandemic
- (2020) Gesa Gnegel et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: a retrospective study
- (2020) N. Lian et al. CLINICAL MICROBIOLOGY AND INFECTION
- Infodemic and the spread of fake news in the COVID-19-era
- (2020) Daniele Orso et al. European Journal of Emergency Medicine
- New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?
- (2020) Christian A. Devaux et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
- (2020) Philippe Gautret et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study
- (2020) Lisi Deng et al. JOURNAL OF INFECTION
- Clinical and demographic characteristics of patients dying from COVID-19 in Italy versus China
- (2020) Giuseppe Lippi et al. JOURNAL OF MEDICAL VIROLOGY
- Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19
- (2020) Hao Cheng et al. JOURNAL OF MEDICAL VIROLOGY
- Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19)
- (2020) Dae-Gyun Ahn et al. JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY
- Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
- (2020) Mandeep R Mehra et al. LANCET
- The proximal origin of SARS-CoV-2
- (2020) Kristian G. Andersen et al. NATURE MEDICINE
- Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19
- (2020) Giuseppe Mancia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19
- (2020) Harmony R. Reynolds et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19
- (2020) Mandeep R. Mehra et al. NEW ENGLAND JOURNAL OF MEDICINE
- WHO launches global megatrial of the four most promising coronavirus treatments
- (2020) Kai Kupferschmidt SCIENCE
- Covid-19: European drugs agency to review safety of ibuprofen
- (2020) Michael Day BMJ-British Medical Journal
- Developing a vaccine for covid-19
- (2020) Sarah Caddy BMJ-British Medical Journal
- Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data
- (2020) Matthieu Mahévas et al. BMJ-British Medical Journal
- Coronavirus Disease 2019 (COVID‐19) and Cardiovascular Disease: A Viewpoint on the Potential Influence of Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers on Onset and Severity of Severe Acute Respiratory Syndrome Coronavirus 2 Infection
- (2020) Junyi Guo et al. Journal of the American Heart Association
- Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
- (2020) Lei Fang et al. Lancet Respiratory Medicine
- Cleaning and Disinfectant Chemical Exposures and Temporal Associations with COVID-19 — National Poison Data System, United States, January 1, 2020–March 31, 2020
- (2020) Arthur Chang et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study
- (2020) Qingxian Cai et al. Engineering
- Epidemiology and clinical features of COVID-19: A review of current literature
- (2020) Juan A. Siordia JOURNAL OF CLINICAL VIROLOGY
- A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19
- (2020) Andrea Cortegiani et al. JOURNAL OF CRITICAL CARE
- Favipiravir as a potential countermeasure against neglected and emerging RNA viruses
- (2018) Leen Delang et al. ANTIVIRAL RESEARCH
- Assessment of the Utility of Social Media for Broad-Ranging Statistical Signal Detection in Pharmacovigilance: Results from the WEB-RADR Project
- (2018) Ola Caster et al. DRUG SAFETY
- The usefulness of listening social media for pharmacovigilance purposes: a systematic review
- (2018) Irma Convertino et al. Expert Opinion On Drug Safety
- The mechanism of resistance to favipiravir in influenza
- (2018) Daniel H. Goldhill et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Combined Effect of Oseltamivir and Favipiravir on Influenza A Virus Evolution
- (2017) Louise Ormond et al. Genome Biology and Evolution
- Antiviral Activity of Chloroquine against Human Coronavirus OC43 Infection in Newborn Mice
- (2009) E. Keyaerts et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Medication errors: what they are, how they happen, and how to avoid them
- (2009) J.K. Aronson QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More